Drug Shortage Report for SANDOZ DICLOFENAC OPHTHA
Report ID | 110109 |
Drug Identification Number | 02454807 |
Brand name | SANDOZ DICLOFENAC OPHTHA |
Common or Proper name | DICLO OPHTHA |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | DICLOFENAC SODIUM |
Strength(s) | 0.1% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC |
Packaging size | 5ml |
ATC code | S01BC |
ATC description | ANTIINFLAMMATORY AGENTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2020-03-16 |
Estimated end date | 2020-08-07 |
Actual end date | 2020-08-03 |
Shortage status | Resolved |
Updated date | 2020-08-24 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2020-08-24 | French | Compare |
v9 | 2020-08-24 | English | Compare |
v8 | 2020-06-29 | French | Compare |
v7 | 2020-06-29 | English | Compare |
v6 | 2020-05-04 | French | Compare |
v5 | 2020-05-04 | English | Compare |
v4 | 2020-04-07 | French | Compare |
v3 | 2020-04-07 | English | Compare |
v2 | 2020-03-30 | French | Compare |
v1 | 2020-03-30 | English | Compare |
Showing 1 to 10 of 10